Cancer is the second leading cause for death worldwide, highlighting the paramount
importance of cancer research. Decades of research has led to many innovative …

In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer
diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora …

Nanotechnology has been used for every single modality in the molecular imaging arena for
imaging purposes. Synergic advantages can be explored when multiple molecular imaging …

In this study, we cover the convergence of radiochemistry for imaging and therapy with
advances in nanoparticle (NP) design for biomedical applications. We first explore NP …

In this review, we emphasize the efforts on the development of radiolabeled nanoparticles
(NPs) for cancer treatment, ie theranostic tools based on nanotechnology and nuclear …

Cancer is the second leading cause of death in the world. Radiolabeled nanocarriers or
nanoparticles can be designed and used for cancer diagnostic and therapeutic purposes …

The current concepts of cancer therapy are moving towards personalized treatment regimen
aiming to reduce toxicity and improve efficacy of therapeutic agents. With the development of …

This review summarizes the current state-of-the-art of radiolabeled nanoparticles for
molecular imaging and internal radiotherapy applications targeting cancer. With the capacity …

Cancer is one of the leading non-communicable diseases with highest mortality rates
worldwide. About half of all cancer patients receive radiation treatment in the course of their …

Current progress in nanomedicine has exploited the possibility of designing tumor‐targeted
nanocarriers being able to deliver radionuclide payloads in a site or molecular selective …